Epidemiology of Endophthalmitis and Treatment Trend in Europe


Reference

Country

Publication year

Period

Total N

IPOE N

IPOE rate (%)

IPOE rate with IC antibiotics

IPOE rate without IC antibiotics (%)

Romero (5)

Spain

2006

2001–2004

7268

25

0.344

0.055% (cefazolin)

0.63

ESCRS (4)

Multiple (EU countries)

2007

2003–2005

15,971

20

0.12

0.05% (cefuroxime)

0.35

Yu-Wai-Man (6)

UK

2008

2000–2006

36,743

35

0.095

0.046% (cefuroxime)

0.139

Garat (7)

Spain

2009

2002–2007

18,579

31

0.167

0.047% (cefazolin)

0.422

Garcia-Saenz (8)

Spain

2010

1999–2008

13,652

42

0.30

0.590%

(cefuroxime)

0.043

Barreau (9)

France

2012

2003–2008

5115

36

0.704

0.044% (cefuroxime)

1.238

Friling (10)

Sweden

2013

2005–2010

464,996

135

0.029

0.027%

(various)

0.39

Rodriguez-Caravaca (11)

Spain

2013

1998–2012

19,463

44

0.23

0.039% (cefuroxime)

0.59

Beselga (12)

Portugal

2014

2005–2011

15,689

6

0.038

0.00% (cefuroxime)

0.26

Rahman and Murphy (13)

Ireland

2015

2007–2011

8239

5

0.061

0.061% (cefuroxime)


Lundstrom (14)

Sweden

2015

2001–2010

692,786

244

0.035

0.03%

(various, 99% cefuroxime)

0.43

Creuzot-Garcher (15)

France

2016

2005–2014

6,371,242

6668

0.105

0.046%–0.111%

(cefuroxime)

0.080–0.46

Daien (16)

France

2016

2010–2014

2,434,008

1941

0.08

0.06%

(cefuroxime)

0.09


IPOE = infectious postoperative endophthalmitis



Intravitreal injections (IVI) (mainly of the anti-VEGF agents) are an increasingly commonly performed procedure. In Europe, most of IVIs are performed in the operating room (OR), while in the USA, the vast majority of specialists perform injections in an office setting. The reported incidence for endophthalmitis after IVIs in several European countries does not exceed 0.06% (Table 5.2) [1826].


Table 5.2
Endophthalmitis rate after IVI




























































































Reference

Country

Publication year

Period

Total N of IVI

Endophthalmitis N

Endophthalmitis rate

McCannel (18)

USA

2011

2005–2009

105,536

52

0.049%

Lommatzsch (19)

Germany

2013

2008–2012

N/aa

27

N/aa

Tabandeh (20)

Italy and USA

2014

2009–2011

11,710

5

0.043%

Casparis (21)

Switzerland

2014

2004–2012

40,011

3

0.0075%

Fileta (22)

Multiple

2014

2005–2012

350,535

197

0.056%

Brynskov (23)

Denmark

2014

2007–2013

20,293

0

0%

Nentwich (24)

Germany

2014

2005–2012

18,202

3

0.016%

Dossarps (25)

France

2014

2008–2013

316,576

65

0.021%

Ramel (26)

France

2015

2007–2012

11,450

6

0.052%


aN/a—no data available

Glaucoma surgery (blebs, glaucoma valve placements) also can cause postoperative endophthalmitis. Estimated incidence of bleb-related endophthalmitis (BRE) is <0.1% in case of early-onset and 0.2% for late-onset endophthalmitis [27, 28]. It has been shown that the BRE incidence rate is higher with adjunctive antimetabolites (up to 3%) [29] and when the bleb is placed inferiorly (up to 9.4%) [30].

Endogenous endophthalmitis (EE) is highly uncommon (approximately 2–8% of all cases of endophthalmitis) and is usually associated with other risk factors of systemic infection, such as diabetes, indwelling catheters, intravenous drug administration, malignancy, and immunodeficiency [31]. Because of the rarity, there are no available large-scale studies on the EE etiology, treatment options, and clinical outcomes of these patients.



Endophthalmitis: Etiology


Endophthalmitis may be caused by the microorganisms derived from conjunctival sac, contaminated devices, irrigating solutions, the implanted intraocular lens, or airborne contamination. The Endophthalmitis Vitrectomy Study has shown that in 67.7% of cases with bacterial postoperative endophthalmitis, the intraocular isolates were indistinguishable from the conjunctival and lid specimens [1]. Microbial spectrum of postoperative endophthalmitis varies in different countries and is dependent on environmental, geographical, or climatic factors. Table 5.3 presents the etiology of postoperative endophthalmitis in different regions. Gram-positive bacteria, including Staphylococcus epidermidis, Staphylococcus aureus, and Streptococcus pneumonia, are the most commonly isolated organisms from endophthalmitis occurring after cataract surgery in Europe; the gram-negative bacteria represent up to 14% of cases [9, 13, 32, 33]. There are, however, significant differences in a rate of enterococcal infections in Sweden (30–31%) and other European countries (2% in the Netherlands and UK), or the USA (3%). This shift in the preponderance of enterococcal endophthalmitis in Sweden may be connected with widespread use of intracameral cefuroxime and increased proportion of cefuroxime-resistant species. In the USA, as in Europe, the most commonly identified microorganisms are coagulase-negative Staphylococci (CONS), whereas the rate of streptococcal infections is lower [34]. In countries such as Taiwan, India, and China, the reported percentage of gram-negative and fungal cases are much higher than in Europe and the USA [3538]. It has been shown that the bacterial virulence level is the main prognostic factor predictive of the final visual result [39].


Table 5.3
Pathogens causing postoperative endophthalmitis in different countries









































































































Pathogens

Lundstrom (13)

Sweden

Friling (9)

Sweden

Mollan (28)

UK

Pijl (29)

Netherlands

Han (30)

USA

Cheng (31)

Taiwan

Anand (32)

India

Kunimoto (33)

India

Sheng (34)

China

Gram-positive organisms
         
44%

37.6%

53%

74%

Staphylococci

35%
               

Staphylococcus aureus
   
5%

12%

10%

24%

8%
 
12%

Coagulase-negative Staphylococcus (CoNS)
 
26%

62%

54%

70%

3%

13%

33%

46%

Enterococci

30%

31%

3%

2%

2%

12%

2%
 
7%

Other gram-positive organisms

13.5%

6%

3%

5%

3%

3%

11%
 
3%

Streptococci
 
7%

20%

19%

9%

3%

4%

10%

6%

Gram-negative organisms (Pseudomonas sp., Enterobacteriaceae sp.)

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Mar 1, 2018 | Posted by in OPHTHALMOLOGY | Comments Off on Epidemiology of Endophthalmitis and Treatment Trend in Europe

Full access? Get Clinical Tree

Get Clinical Tree app for offline access